Hexacima

инжекционна суспензия · --¹ One dose¹ (0.5 ml) contains: Diphtheria Toxoid not less than 20 IU (30 Lf) Tetanus Toxoid not less than 40 IU (10 Lf) Bordetella pertussis antigens Pertussis Toxoid 25 micrograms Filamentous Haemagglutinin 25 micrograms Poliovirus (Inactivated) Type 1 (Mahoney) 29 D-antigen units Type 2 (MEF-1) 7 D-antigen units Type 3 (Saukett) 26 D-antigen units Hepatitis B surface antigen 10 micrograms Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein 22-36 micrograms ¹ Adsorbed on aluminium hydroxide, hydrated (0.6 mg Al³⁺) · Sanofi Winthrop Industrie

Основни характеристики

Активно вещество	diphtheria, tetanus, pertussis (acellular, component), hepatitis b (rdna), poliomyelitis (inact.) and haemophilus type b conjugate vaccine (adsorbed)
Лекарствена форма	инжекционна суспензия
Концентрация	--¹ One dose¹ (0.5 ml) contains: Diphtheria Toxoid not less than 20 IU (30 Lf) Tetanus Toxoid not less than 40 IU (10 Lf) Bordetella pertussis antigens Pertussis Toxoid 25 micrograms Filamentous Haemagglutinin 25 micrograms Poliovirus (Inactivated) Type 1 (Mahoney) 29 D-antigen units Type 2 (MEF-1) 7 D-antigen units Type 3 (Saukett) 26 D-antigen units Hepatitis B surface antigen 10 micrograms Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein 22-36 micrograms ¹ Adsorbed on aluminium hydroxide, hydrated (0.6 mg Al³⁺)
Режим на отпускане	Не е посочен
Притежател на разрешението	Sanofi Winthrop Industrie
ATC код	J07CA09 — diphtheria-haemophilus influenzae B-pertussis-poliomyelitis-tetanus-hepatitis B

Пълна листовка

Алтернативи със същата активна съставка

Изброени са продуктите със същата активна съставка. Алтернативите могат да се различават по производител, концентрация и опаковка. Консултирайте се с лекар или фармацевт преди да преминете на друг продукт.

Търговско име

Концентрация

Hexyon

--¹ One dose¹ (0.5 ml) contains: Diphtheria Toxoid not less than 20 IU (30 Lf) Tetanus Toxoid not less than 40 IU (10 Lf) Bordetella pertussis antigens Pertussis Toxoid 25 micrograms Filamentous Haemagglutinin 25 micrograms Poliovirus (Inactivated) Type 1 (Mahoney) 29 D-antigen units Type 2 (MEF-1) 7 D-antigen units Type 3 (Saukett) 26 D-antigen units Hepatitis B surface antigen 10 micrograms Haemophilus influenzae type b polysaccharide 12 micrograms (Polyribosylribitol Phosphate) conjugated to Tetanus protein 22-36 micrograms ¹ Adsorbed on aluminium hydroxide, hydrated (0.6 mg Al³⁺)

Vaxelis

--¹ One dose (0.5 ml) contains: Diphtheria Toxoid¹: 15 Lf (≥ 20 IU)⁶ Tetanus Toxoid¹: 5 Lf (≥ 40 IU)⁶ Bordetella pertussis antigens¹: Pertussis Toxoid (PT) 20 micrograms Filamentous Haemagglutinin (FHA) 20 micrograms Pertactin (PRN) 3 micrograms Fimbriae Types 2 and 3 (FIM) 5 micrograms Hepatitis B surface antigen²,³: 10 micrograms Poliovirus (Inactivated)⁴: Type 1 (Mahoney) 29 D antigen units⁵ Type 2 (MEF-1) 7 D antigen units⁵ Type 3 (Saukett) 26 D antigen units⁵ Haemophilus influenzae type b polysaccharide (Polyribosylribitol Phosphate) 3 micrograms Conjugated to meningococcal protein² 50 micrograms ¹ adsorbed on aluminium phosphate (0.17 mg Al³⁺) ² adsorbed on amorphous aluminium hydroxyphosphate sulfate (0.15 mg Al³⁺) ³ produced in yeast (Saccharomyces cerevisiae) cells by recombinant DNA technology ⁴ produced in Vero cells ⁵ These antigen quantities are strictly the same as those previously expressed as 40-8-32 D-antigen units, for virus type 1, 2 and 3 respectively, when measured by another suitable immunochemical method ⁶ or equivalent activity determined by an immunogenicity or antigenicity evaluation.

Важно: Информацията на тази страница е въз основа на официалната листовка, разрешена от Изпълнителната агенция по лекарствата (ИАЛ). Тя не замества консултация с лекар или фармацевт. При съмнения относно прием на лекарства, потърсете квалифицирана медицинска помощ.

За съобщаване на нежелана лекарствена реакция, използвайте формуляра на ИАЛ.